Codexis, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
CDXS
Codexis, INCH. Stewart Parker, a Director at Codexis, Inc., acquired 66,350 stock options with an exercise price of $2.48.
NASDAQ
CDXS
Codexis, INCCynthia Collins, a Director at Codexis, Inc., acquired stock options granting the right to buy 66,350 shares.
NASDAQ
CDXS
Codexis, INCCodexis Director Christos Richards acquired 66,350 stock options with an exercise price of $2.48, vesting on June 17, 2026.
NASDAQ
CDXS
Codexis, INCDavid V. Smith, a Director at Codexis, Inc., acquired 66,350 stock options with an exercise price of $2.48, vesting on June 17, 2026.
NASDAQ
CDXS
Codexis, INCDirector Rahul Singhvi of Codexis, Inc. reported the acquisition of stock options, indicating a vested interest in the company's future performance.
NASDAQ
CDXS
Codexis, INCCodexis, Inc. director Esther Martinborough acquired stock options for 66,350 shares of common stock.
NASDAQ
CDXS
Codexis, INCCodexis, Inc. Director Stephen George Dilly acquired 66,350 stock options with an exercise price of $2.48, vesting on June 17, 2026.
NASDAQ
CDXS
Codexis, INCDirector Raymond De Vre sold 2,605 shares of Codexis, Inc. to cover tax obligations related to RSU vesting.
NASDAQ
CDXS
Codexis, INCCodexis Chief Scientific Officer Stefan Lutz reported a sale of common stock to cover tax obligations and the grant of 316,100 new stock options.
NASDAQ
CDXS
Codexis, INCCodexis, Inc. President and CEO Alison Moore was granted 993,000 stock options with an exercise price of $1.07, vesting over four years.
NASDAQ
CDXS
Codexis, INCCodexis, Inc. Chief Financial Officer and Chief Business Officer Georgia Erbez was granted 316,100 stock options with a $1.07 exercise price.
NASDAQ
CDXS
Codexis, INCCodexis Chief Scientific Officer Stefan Lutz sold 2,492 shares of common stock to cover tax withholding obligations related to RSU vesting.
NASDAQ
CDXS
Codexis, INCCodexis' Chief Financial Officer, Georgia Erbez, sold 3,826 shares of common stock to cover tax withholding obligations related to RSU vesting.
NASDAQ
CDXS
Codexis, INCCodexis Chief Scientific Officer Stefan Lutz sold 4,685 shares of common stock to cover tax liabilities from restricted stock unit vesting.
NASDAQ
CDXS
Codexis, INCOpaleye Management Inc. filed an amended Form 4 to correct a clerical error, disclosing dispositions of CODEXIS, INC. common stock totaling 514,341 shares across multiple transactions in late November and early December 2025.
NASDAQ
CDXS
Codexis, INCOpaleye Management Inc. filed an amended Form 4 correcting a clerical error to reflect dispositions of CODEXIS, INC. common stock totaling over 1 million shares.
NASDAQ
CDXS
Codexis, INCOpaleye Management Inc., a 10% owner and director of Codexis, Inc., reported multiple sales of common stock totaling 519,341 shares in late November and early December 2025.
NASDAQ
CDXS
Codexis, INCA director at Codexis, Dennis P. Wolf, sold 8,952 shares of common stock for a weighted average price of $1.5626 per share under a pre-arranged trading plan.
NASDAQ
CDXS
Codexis, INCCodexis President and CEO Alison Moore was granted 85,000 restricted stock units and 500,000 stock options on November 13, 2025.
NASDAQ
CDXS
Codexis, INCOpaleye Management Inc., a 10% owner and director of Codexis, Inc., reported the sale of over 1 million shares of common stock in multiple transactions.
NASDAQ
CDXS
Codexis, INCCODEXIS, INC. Director Raymond De Vre sold 1,413 shares of common stock at $1.74 per share to cover tax liabilities from vested Restricted Stock Units.
NASDAQ
CDXS
Codexis, INCCodexis Director Stephen Dilly acquired 50,000 shares of common stock at a weighted average price of $1.8473, increasing his direct beneficial ownership.
NASDAQ
CDXS
Codexis, INCOpaleye Management Inc., a 10% owner and director of Codexis, Inc., reported the sale of over 1 million shares of common stock across multiple transactions in November 2025.
NASDAQ
CDXS
Codexis, INCCodexis Chief Technical Officer Alison Moore sold 6,239 shares of common stock to cover tax withholding obligations related to RSU vesting.
NASDAQ
CDXS
Codexis, INCCodexis Chief Financial Officer, Georgia Erbez, sold 6,239 shares of common stock to cover tax withholding related to RSU vesting.
NASDAQ
CDXS
Codexis, INCOpaleye Management Inc., a 10% owner of Codexis, Inc., increased its indirect beneficial ownership of common stock through recent purchases.
NASDAQ
CDXS
Codexis, INCOpaleye Management Inc., a significant 10% owner, has increased its indirect beneficial ownership in Codexis, Inc. through recent common stock acquisitions.
NASDAQ
CDXS
Codexis, INCOpaleye Management Inc., a 10% owner and director of Codexis, Inc., acquired 100,000 shares of common stock at $2.82 per share, increasing its indirect beneficial ownership.
NASDAQ
CDXS
Codexis, INCOpaleye Management Inc., a 10% owner of Codexis, Inc., acquired an additional 100,000 shares of common stock at $2.39 per share, increasing its total indirect beneficial ownership to 12,600,000 shares.
NASDAQ
CDXS
Codexis, INCOpaleye Management Inc., a 10% owner and director of Codexis, Inc., has increased its beneficial ownership through recent stock purchases totaling 250,000 shares.